The efficacy and drug survival of the biosimilar infliximab (ct-p13) compared to the original reference infliximab in inflammatory rheumatic diseases; Results from the turkbio registry

dc.contributor.authorUslu, Sadettin
dc.contributor.authorCan, Gerçek
dc.contributor.authorŞenel, Soner
dc.contributor.authorİnanç, Nevsun
dc.contributor.authorAkars, Servet
dc.contributor.authorKocaer, Sinem Burcu
dc.contributor.authorBirlik, Merih
dc.contributor.authorCapar, Sedat
dc.contributor.authorAkkoç, Nurullah
dc.contributor.authorÖnen, Fatoş
dc.contributor.buuauthorDalkılıç, Ediz
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Romatoloji Bilim Dalı.tr_TR
dc.date.accessioned2024-01-08T10:09:21Z
dc.date.available2024-01-08T10:09:21Z
dc.date.issued2018-09
dc.identifier.citationUslu, S. vd. (2018). ''The efficacy and drug survival of the biosimilar infliximab (ct-p13) compared to the original reference infliximab in inflammatory rheumatic diseases; Results from the turkbio registry''. Arthritis & Rheumatology, 70(Supplement 9).
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.issueSupplement 9
dc.identifier.urihttps://hdl.handle.net/11452/38832
dc.identifier.volume70tr_TR
dc.identifier.wos000447268904265
dc.indexed.pubmedPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalArthritis & Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRheumatologyen_US
dc.subject.wosRheumatologyen_US
dc.titleThe efficacy and drug survival of the biosimilar infliximab (ct-p13) compared to the original reference infliximab in inflammatory rheumatic diseases; Results from the turkbio registryen_US
dc.typeArticleen_US
dc.wos.quartileQ1 (Rheumatology)

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections